You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Irreversible P2Y12 antagonist; metabolised to active metabolite R-99224 (IC50 = 45 μM) irreversibly binds platelet P2Y12 receptors, inhibiting platelet activation. Antiplatelet and antithrombotic. Orally active and active in vivo. Note - inactive in vitro.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 373.44. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.68 mL||13.39 mL||26.78 mL|
|5 mM||0.54 mL||2.68 mL||5.36 mL|
|10 mM||0.27 mL||1.34 mL||2.68 mL|
|50 mM||0.05 mL||0.27 mL||0.54 mL|
References are publications that support the biological activity of the product.
Sugidachi et al (2000) The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties. Br.J.Pharmacol. 129 1439 PMID: 10742300
Hashimoto (2007) The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of pras. in a mouse model: evidence for specific inhibition of P2Y12 receptors by pras. Biochem.Pharmacol. 74 1003 PMID: 17681285
Huber et al (2009) Prasugrel. Nat.Rev.Drug Discov. 8 449 PMID: 19483707
If you know of a relevant reference for Prasugrel, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Prasugrel, Prasugrel supplier, LY640315, Prasugrel, P2Y12, purinergic, antagonists, receptors, purinoceptors, adenosine, CS_747, CS747, Effient, Efient, antiplatelet, atherosclerosis, antithromboembolic, orally, active, in, vivo, CS, 747, Purinergic, P2Y, Receptors, 6317, Tocris Bioscience
Citations for Prasugrel
Citations are publications that use Tocris products.
Currently there are no citations for Prasugrel. Do you know of a great paper that uses Prasugrel from Tocris? Please let us know.
Reviews for Prasugrel
There are currently no reviews for this product. Be the first to review Prasugrel and earn rewards!
Have you used Prasugrel?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.